These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease. Varadharajan V; Arumugam GS; Shanmugam S J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269 [TBL] [Abstract][Full Text] [Related]
6. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M Kapusta K; Kar S; Collins JT; Franklin LM; Kolodziejczyk W; Leszczynski J; Hill GA J Biomol Struct Dyn; 2021 Oct; 39(17):6810-6827. PubMed ID: 32795148 [TBL] [Abstract][Full Text] [Related]
7. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods. Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552 [TBL] [Abstract][Full Text] [Related]
8. Some Flavolignans as Potent Sars-Cov-2 Inhibitors Cetin A Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852 [TBL] [Abstract][Full Text] [Related]
9. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies. Roy R; Sk MF; Jonniya NA; Poddar S; Kar P J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642 [TBL] [Abstract][Full Text] [Related]
10. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease. Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750 [TBL] [Abstract][Full Text] [Related]
11. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies. Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578 [TBL] [Abstract][Full Text] [Related]
13. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Kavitha K; Sivakumar S; Ramesh B Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567 [TBL] [Abstract][Full Text] [Related]
14. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease. Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983 [TBL] [Abstract][Full Text] [Related]
15. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
16. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783 [TBL] [Abstract][Full Text] [Related]
17. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956 [TBL] [Abstract][Full Text] [Related]
19. Traditional herbal compounds as candidates to inhibit the SARS-CoV-2 main protease: an de Oliveira OV; Cristina Andreazza Costa M; Marques da Costa R; Giordano Viegas R; Paluch AS; Miguel Castro Ferreira M J Biomol Struct Dyn; 2023 Mar; 41(5):1603-1616. PubMed ID: 36719113 [TBL] [Abstract][Full Text] [Related]
20. An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration. El-Saghier AM; Enaili SS; Abdou A; Kadry AM Mol Divers; 2024 Feb; 28(1):249-270. PubMed ID: 37946070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]